Association between cardiac autonomic function, oxidative stress and inflammatory response in impaired fasting glucose subjects: Cross-sectional study

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Thiyagarajan, Ramkumar ^a   Subramanian, Senthil Kumar ^a   Sampath, Nishanth ^a   Trakroo, Madanmohan ^a   Pal, Pravati ^a   Bobby, Zachariah ^a   Paneerselvam, Sankar ^a   Das, Ashok Kumar ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM FUNCTION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CROSS-SECTIONAL STUDY; DIABETIC NEUROPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; HEART AUTONOMIC FUNCTION; HEART FUNCTION; HEART RATE; HUMAN; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; ORTHOSTATIC STRESS; OXIDATIVE STRESS; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VASOCONSTRICTION;

ADULT; AUTONOMIC NERVOUS SYSTEM; BLOOD GLUCOSE; BLOOD PRESSURE; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; HEART RATE; HUMANS; INFLAMMATION MEDIATORS; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PREDIABETIC STATE; RISK FACTORS; STATISTICS, NONPARAMETRIC; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TUMOR NECROSIS FACTOR-ALPHA; VALSALVA MANEUVER;

EID: 84864443167     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041889     Document Type: Article

References (45)

1. Whiting DR, Guariguata L, Weil C, Shaw J, ((2011)) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:: 311--321 doi:10.1016/j.diabres.2011.10.029.
2. Shah B, Mathur P, ((2010)) Surveillance of cardiovascular disease risk factors in India: the need & scope. Indian J Med Res 132:: 634--642.
3. Yusuf S, Reddy S, Ounpuu S, Anand S, ((2001)) Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 104:: 2855--2864.
4. Larson H, Lindgarde F, Berglund G, Ahren B, ((2004)) Prediction of diabetes using ADA or WHO criteria in post-menopausal women: a 10-year follow-up study. Diabetologia 43:: 1224--1228 doi:10.1007/s001250051516.
5. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, et al. ((2003)) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:: 3160--3167.
6. Ford ES, Zhao G, Li C, ((2010)) Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J Am Coll Cardiol 55:: 1310--1317 doi:10.1016/j.jacc.2009.10.060.
7. Dunstan DW, Zimmet PZ, Welborn TA, de Court, Cameron AJ, et al. ((2002)) The Rising Prevalence of Diabetes and Impaired Glucose Tolerance. Diabetes Care 25:: 829--834.
8. Shaw JE, Zimmet PZ, de Court, Dowse GK, Chitson P, et al. ((1999)) Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? Diabetes Care 22:: 399--402.
9. Hanefeld M, Koehler C, Fuecker K, Henkel E, Schaper F, et al. ((2003)) Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study. Diabetes Care 26:: 868--874.
10. Smith NL, Barzilay JI, Shaffer D, Savage PJ, Heckbert SR, et al. ((2002)) Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study. Arch Intern Med 162:: 209--216.
11. Meigs JB, Muller DC, Nathan DM, Blake DR, Andres R, ((2003)) The Natural History of Progression From Normal Glucose Tolerance to Type 2 Diabetes in the Baltimore Longitudinal Study of Aging. Diabetes 52:: 1475--1484.
12. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus ((1997)) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:: 1183--1197.
13. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, et al. ((1999)) Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 22:: 920--924.
14. Chakarova N, Tankova T, Atanassova I, Dakovska L, ((2009)) Serum lipid and hsCRP levels in prediabetes-impaired fasting glucose (IFG) and impaired glucose tolerance (IGT). Diabetes Res Clin Pract 86:: 56--60 doi:10.1016/j.diabres.2009.04.005.
15. Karason K, Molgaard H, Wikstrand J, Sjostrom L, ((1999)) Heart rate variability in obesity and the effect of weight loss. Am J Cardiol 83:: 1242--1247.
16. Ewing DJ, Martyn CN, Young RJ, Clarke BF, ((1985)) The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 8:: 491--498.
17. Wu JS, Yang YC, Lin TS, Huang YH, Chen JJ, et al. ((2007)) Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose. J Clin Endocrinol Metab 92:: 3885--3889 doi:10.1210/jc.2006-2175.
18. Lee S, Cowan PA, Wetzel GT, Velasquez-Mieyer P, ((2011)) Prediabetes and blood pressure effects on heart rate variability, QT-interval duration, and left ventricular hypertrophy in overweight-obese adolescents. J Pediatr Nurs 26:: 416--427 doi:10.1016/j.pedn.2010.08.008.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. ((1985)) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:: 412--419.
20. Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA, ((1987)) Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 113:: 1489--1494.
21. Wu JS, Yang YC, Lu FH, Wu CH, Wang RH, et al. ((2009)) Population-based study on the prevalence and risk factors of orthostatic hypotension in subjects with pre-diabetes and diabetes. Diabetes Care 32:: 69--74 doi:10.2337/dc08-1389.
22. Laederach-Hofmann K, Mussgay L, Winter A, Klinkenberg N, Ruddel H, ((1999)) Early autonomic dysfunction in patients with diabetes mellitus assessed by spectral analysis of heart rate and blood pressure variability. Clin Physiol 19:: 97--106.
23. Teff KL, ((2008)) Visceral Nerves: Vagal and Sympathetic Innervation. Journal of Parenteral and Enteral Nutrition 32:: 569--571.
24. Haffner SM, ((2003)) Pre-diabetes, insulin resistance, inflammation and CVD risk. Diabetes Res Clin Pract 61 (Suppl 1): S9--S18.
25. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, et al. ((2000)) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:: 787--790 doi:10.1038/35008121.
26. McCarty MF, ((2002)) Insulin's stimulation of endothelial superoxide generation may reflect up-regulation of isoprenyl transferase activity that promotes rac translocation. Med Hypotheses 58:: 472--475.
27. Styskal J, Van RH, Richardson A, Salmon AB, ((2011)) Oxidative stress and diabetes: What can we learn about insulin resistance from antioxidant mutant mouse models? Free Radic Biol Med. doi:10.1016/j.freeradbiomed.2011.10.441.
28. Su Y, Liu XM, Sun YM, Jin HB, Fu R, et al. ((2008)) The relationship between endothelial dysfunction and oxidative stress in diabetes and prediabetes. Int J Clin Pract 62:: 877--882 doi:10.1111/j.1742-1241.2008.01776.x.
29. Turk HM, Sevinc A, Camci C, Cigli A, Buyukberber S, et al. ((2002)) Plasma lipid peroxidation products and antioxidant enzyme activities in patients with type 2 diabetes mellitus. Acta Diabetol 39:: 117--122 doi:10.1007/s005920200029.
30. Mazzone T, Chait A, Plutzky J, ((2008)) Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet 371:: 1800--1809 doi:10.1016/S0140-6736(08)60768-0.
31. Blake DR, Meigs JB, Muller DC, Najjar SS, Andres R, et al. ((2004)) Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging. Diabetes 53:: 2095--2100.
32. Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A, ((2008)) Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care 31:: 464--469 doi:10.2337/dc07-1796.
33. Gerritsen J, Dekker JM, TenVoorde BJ, Bertelsmann FW, Kostense PJ, et al. ((2000)) Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn Study. Diabetologia 43:: 561--570 doi:10.1007/s001250051344.
34. Gerritsen J, Dekker JM, TenVoorde BJ, Kostense PJ, Heine RJ, et al. ((2001)) Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care 24:: 1793--1798.
35. Verschuren WM, Jacobs DR, Bloemberg BP, Kromhout D, Menotti A, et al. ((1995)) Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA 274:: 131--136.
36. Hokanson JE, Austin MA, ((1996)) Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3:: 213--219.
37. Gaziano JM, Hennekens CH, O'Donnell CJ, Breslow JL, Buring JE, ((1997)) Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation 96:: 2520--2525.
38. Alberti KG, Zimmet P, Shaw J, ((2006)) Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23:: 469--480 doi:10.1111/j.1464-5491.2006.01858.x.
39. O'Brien IA, O'Hare P, Corrall RJ, ((1986)) Heart rate variability in healthy subjects: effect of age and the derivation of normal ranges for tests of autonomic function. Br Heart J 55:: 348--354.
40. Ryan SM, Goldberger AL, Pincus SM, Mietus J, Lipsitz LA, ((1994)) Gender- and age-related differences in heart rate dynamics: are women more complex than men? J Am Coll Cardiol 24:: 1700--1707.
41. Rennie KL, Hemingway H, Kumari M, Brunner E, Malik M, et al. ((2003)) Effects of moderate and vigorous physical activity on heart rate variability in a British study of civil servants. Am J Epidemiol 158:: 135--143.
42. Foy CG, Foley KL, D'Agostino RB, Goff DC, Mayer-Davis E, et al. ((2006)) Physical Activity, Insulin Sensitivity, and Hypertension among US Adults: Findings from the Insulin Resistance Atherosclerosis Study. American Journal of Epidemiology 163:: 921--928.
43. Wood PD, Stefanick ML, Williams PT, Haskell WL, ((1991)) The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. N Engl J Med 325:: 461--466 doi:10.1056/NEJM199108153250703.
44. Hamman RF, Wing RR, Edelstein SL, Lachin JM, Bray GA, et al. ((2006)) Effect of Weight Loss With Lifestyle Intervention on Risk of Diabetes. Diabetes Care 29:: 2102--2107.
45. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al. ((2003)) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289:: 2560--2572 doi:10.1001/jama.289.19.2560.